patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Bankerson, I believe within the next 12 months we

will see at least a 2 for 1 split and the share price climbs rapidly. OK, I'm dreaming, but I believe this stock has that kind of potential due to the relatively small float.

Share
New Message
Please login to post a reply